Adaptimmune Reports Q1 Financial Results
– Upfront payment of $50m received from Astellas and approximately $90m offering completed – – Financial [...]
Surface Oncology to Present at the American Society of Clinical Oncology Annual Meeting
CAMBRIDGE, Mass., May 14, 2020 (GLOBE NEWSWIRE) — Surface Oncology (Nasdaq: SURF), a clinical-stage immuno-oncology company developing next-generation immunotherapies that target […]
TSX News -
Colliers International Launches Offering of Convertible Senior Subordinated Notes
TORONTO, May 14, 2020 (GLOBE NEWSWIRE) — Colliers International Group Inc. (NASDAQ and TSX: CIGI) (“Colliers”) announced today that it […]
TSX News -
Helix BioPharma Corp. L-DOS47 Phase I Lung Cancer Trial Data to be released at ASCO 2020
RICHMOND HILL, Ontario, May 14, 2020 (GLOBE NEWSWIRE) — Helix BioPharma Corp. (TSX: HBP) (“Helix” or the “Company”), an immuno-oncology […]
FTI Consulting’s Jordan Rae Kelly Named to Global Investigations Review’s 40 Under 40 List
WASHINGTON, May 14, 2020 (GLOBE NEWSWIRE) — FTI Consulting, Inc. (NYSE: FCN) today announced that Jordan Rae Kelly, a Senior […]
Trinity Biotech plc to Announce First Quarter 2020 Financial Results
DUBLIN, Ireland, May 14, 2020 (GLOBE NEWSWIRE) — Trinity Biotech plc (Nasdaq: TRIB), a leading developer and manufacturer of diagnostic […]
Net1 to Host Conference Call to Review Third Quarter 2020 Results
JOHANNESBURG, South Africa, May 14, 2020 (GLOBE NEWSWIRE) — Net 1 UEPS Technologies, Inc. (NasdaqGS: UEPS; JSE: NT1) (“Net1”) today […]
Kitov to Present Phase 1 Data on CM-24 in Patients with Advanced Cancer at American Society of Clinical Oncology 2020 Virtual Scientific Program
Company Expects to Initiate Phase 1/2 Clinical trial, in Collaboration with Bristol Myers Squibb, with CM-24 in Combination with nivolumab […]
Sol-Gel Technologies Reports First Quarter 2020 Financial Results and Corporate Update
New Drug Applications for Epsolay® and Twyneo® remain on track for the second quarter and second half 2020, respectivelyCompleted a […]
Cocrystal Pharma Reports First Quarter 2020 Financial Results and Provides Updates on Antiviral Programs
– Company has sufficient capital to advance pipeline and fund operations through 2021 –BOTHELL, WA, May 14, 2020 (GLOBE NEWSWIRE) […]
